Fig. 1From: Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapyThree major pathways involved in vasodilation and vasoconstriction. a Schematic overview of the major pathways and the key proteins involved in vasodilation and vasoconstriction. b Aberrant expression of key factors in the three pathways in both human and rat congenital diaphragmatic hernia (CDH). Solid arrows represent up- or downregulation in human CDH, dashed arrows represent up- or downregulation in rat CDH. ECE-1Â =Â endothelin converting enzyme 1, ETAÂ =Â endothelin A, ETBÂ =Â endothelin B, eNOSÂ =Â endothelial nitric oxide synthase, sGCÂ =Â soluble guanylate cyclase, COXÂ =Â cyclooxygenase, PGISÂ =Â prostaglandin synthase, PGI2Â =Â prostaglandin I2, ACÂ =Â adenylate cyclase, TBXAS1Â =Â thromboxane synthase, TXA2Â =Â thromboxaneBack to article page